Evaluation of the effectiveness of traditional medicine combination based on the Ferula assa-foetida gum - Tragacanth in Participants with Moderate to Severe Coronavirus Disease (COVID-19)

Phase 3

• Conditions: COVID-19.; COVID-19; U07.1

• Registration Number: IRCT20200607047675N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 122

Inclusion Criteria

PCR confirmed
diagnostic chest CT scan
Consent for voluntary participation
Hospitalization

Exclusion Criteria

Patients with end stage heart failure
Recent cardiac intervention (less than 2 months): coronary angioplasty, ICD, CABG, Valvuloplasty or replacement
Pulmonary fibrosis or advanced COPD
End stage kidney or liver disease
Pregnant or lactating ladies
Patients on immunosuppressive therapy
Active tuberculosis
Active hepatitis
The critical stage of COID19

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Oxygen saturation (=94% on room air). Timepoint: Day 1 and 14. Method of measurement: pulse oximetry.;Lymphocyte count. Timepoint: Day 1 and 14. Method of measurement: Complete Blood Count.